Half a Century of Wilson & Jungner: Reflections on the Governance of Population Screening

Steve Sturdy (Lead / Corresponding author), Fiona Miller, Stuart Hogarth, Natalie Armstrong, Pranesh Chakraborty, Celine Cressman, Mark Dobrow, Kathy Flitcroft, David Grossman, Russell Harris, Barbara Hoebee, Kelly Holloway, Linda Kinsinger, Marlene Krag, Olga Löblová, Ilana Löwy, Anne Mackie, John Marshall, Jane O'Hallahan, Linda RabeneckAngela Raffle, Lynette Reid, Graham Shortland, Robert Steele, Beth Tarini, Sian Taylor-Phillips, Bernie Towler, Nynke van der Veen, Marco Zappa

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)
74 Downloads (Pure)


Background: In their landmark report on the "Principles and Practice of Screening for Disease" (1968), Wilson and Jungner noted that the practice of screening is just as important for securing beneficial outcomes and avoiding harms as the formulation of principles. Many jurisdictions have since established various kinds of "screening governance organizations" to provide oversight of screening practice. Yet to date there has been relatively little reflection on the nature and organization of screening governance itself, or on how different governance arrangements affect the way screening is implemented and perceived and the balance of benefits and harms it delivers.

Methods: An international expert policy workshop convened by Sturdy, Miller and Hogarth.

Results: While effective governance is essential to promote beneficial screening practices and avoid attendant harms, screening governance organizations face enduring challenges. These challenges are social and ethical as much as technical. Evidence-based adjudication of the benefits and harms of population screening must take account of factors that inform the production and interpretation of evidence, including the divergent professional, financial and personal commitments of stakeholders. Similarly, when planning and overseeing organized screening programs, screening governance organizations must persuade or compel multiple stakeholders to work together to a common end. Screening governance organizations in different jurisdictions vary widely in how they are constituted, how they relate to other interested organizations and actors, and what powers and authority they wield. Yet we know little about how these differences affect the way screening is implemented, and with what consequences.

Conclusions: Systematic research into how screening governance is organized in different jurisdictions would facilitate policy learning to address enduring challenges. Even without such research, informal exchange and sharing of experiences between screening governance organizations can deliver invaluable insights into the social as well as the technical aspects of governance.

Original languageEnglish
Article number158
Number of pages17
JournalWellcome Open Research
Publication statusPublished - 6 Jul 2020


  • Governance
  • Screening

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • General Biochemistry,Genetics and Molecular Biology


Dive into the research topics of 'Half a Century of Wilson & Jungner: Reflections on the Governance of Population Screening'. Together they form a unique fingerprint.

Cite this